Skip Navigation


JAC Advance Access originally published online on February 17, 2009
Journal of Antimicrobial Chemotherapy 2009 63(4):633-635; doi:10.1093/jac/dkp039
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
63/4/633    most recent
dkp039v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Finch, R.
Right arrow Articles by Sharland, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finch, R.
Right arrow Articles by Sharland, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Leading articles

18 November and beyond: observations on the EU Antibiotic Awareness Day

Roger Finch1,* and Mike Sharland2

1 Division of Microbiology and Infectious Diseases, School of Molecular Medical Sciences, University of Nottingham, The Nottingham University Hospitals NHS Trust, The City Hospital Campus, Clinical Sciences Building, Nottingham NG5 1PB, UK 2 Paediatric Infectious Diseases Unit, St Georges Hospital, Blackshaw Road, London SW17 0QT, UK

* Corresponding author. Tel: +44-115-823-1828; Fax: +44-115-823-1943; E-mail: R.Finch{at}nottingham.ac.uk

Antibiotic resistance is among the greatest threats to public health. Public and political concerns have been important drivers of a multifaceted strategy to contain and control this problem. The key components include surveillance of resistant pathogens and more accurate measurement of prescribing practice, in addition to adherence to sound hygiene and infection control practices. With the current inadequate supply of new antibiotics, better use of existing agents is fundamental. An educational strategy must involve the public as well as prescribing professionals. Public educational initiatives and campaigns have been increasingly used, often effectively. To this end, an annual Antibiotic Awareness Day (AAD) has been launched by the European Union (EU) under the leadership of the European Centre for Disease Control. Across Europe, a repertoire of events took place with the aim of raising public and professional awareness of the importance of appropriate antibiotic use. Only time will tell whether the annual 18 November EUAAD will have significant impact. The need to sustain the effectiveness of these drugs suggests that every effort should be made to ensure that it is successful.

Keywords: antibiotics , antibiotic resistance , education , European Union, prescribing


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
M. S. Dryden, J. Cooke, and P. Davey
Antibiotic stewardship--more education and regulation not more availability?
J. Antimicrob. Chemother., November 1, 2009; 64(5): 885 - 888.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.